chitosan has been researched along with quetiapine fumarate in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Khunt, D; Misra, M; Padh, H; Shah, B | 2 |
Anasooya Shaji, C; Isbell, CL; Kurek, S; Regner, JL; Robinson, BD; Tharakan, B | 1 |
Gadhave, D; Goyal, M; Gupta, V; Quadros, M; Ugale, AR | 1 |
4 other study(ies) available for chitosan and quetiapine fumarate
Article | Year |
---|---|
"Application of Box-Behnken design for optimization and development of quetiapine fumarate loaded chitosan nanoparticles for brain delivery via intranasal route* ".
Topics: Administration, Intranasal; Animals; Antipsychotic Agents; Area Under Curve; Biological Availability; Brain; Chitosan; Drug Carriers; Drug Compounding; Factor Analysis, Statistical; Goats; Nanoparticles; Nasal Mucosa; Particle Size; Permeability; Polyphosphates; Quetiapine Fumarate; Rats, Sprague-Dawley; Tissue Culture Techniques; Tissue Distribution | 2016 |
Non-invasive intranasal delivery of quetiapine fumarate loaded microemulsion for brain targeting: Formulation, physicochemical and pharmacokinetic consideration.
Topics: Administration, Intranasal; Animals; Antipsychotic Agents; Brain; Chemistry, Pharmaceutical; Chitosan; Drug Delivery Systems; Emulsions; Intestinal Mucosa; Lipids; Nasal Mucosa; Quetiapine Fumarate; Rats, Sprague-Dawley; Surface-Active Agents | 2016 |
Quetiapine protects the blood-brain barrier in traumatic brain injury.
Topics: Animals; Antipsychotic Agents; beta Catenin; Blood-Brain Barrier; Brain; Brain Injuries, Traumatic; Cells, Cultured; Chitosan; Computer Simulation; Disease Models, Animal; Electric Impedance; Endothelial Cells; Humans; Intravital Microscopy; Male; Matrix Metalloproteinase 9; Mice; Mice, Inbred C57BL; Microvessels; Models, Molecular; Permeability; Quetiapine Fumarate; Rats; Tight Junctions; Zonula Occludens-1 Protein | 2018 |
A Nanoemulgel for Nose-to-Brain delivery of Quetiapine - QbD-Enabled formulation development & in-vitro characterization.
Topics: Antipsychotic Agents; Brain; Chitosan; Humans; Poloxamer; Quetiapine Fumarate | 2023 |